Challenges in Managing Depression in Clinical Practice: Result of a Global Survey
Abstract
:1. Introduction
2. Results
2.1. Common Challenges in Managing Depression
2.2. Identification of Depression
2.3. Unmet Needs of Psychological Intervention
2.4. Antidepressant Medications
2.5. Medications Prescribed Alongside Antidepressants
2.6. Augmenting Agents
2.7. Type of Depression
2.8. Common Reasons for Treatment Discontinuation
2.9. Continuity of Care Issues
2.10. Treatment Availability
2.11. Treatment Cost
2.12. Suggestions for Solutions
3. Discussion
3.1. Identifying Depression
3.2. Medicinal Treatment
3.3. Availability of Treatment Modalities
3.4. Challenges in Continuity of Care
3.5. Treatment Non-Adherence
3.6. Side Effects Leading to Discontinuation
3.7. Challenges of Managing TRD
3.8. Challenges of Managing Bipolar Depression
3.9. Depression with Comorbidities
3.10. Psychological Intervention
3.11. Affordability of the Treatment Cost
3.12. Managing Stigma
3.13. Limitations
4. Materials and Methods
4.1. Setting
4.2. Participants
4.3. Recruitment
4.4. Questionnaire
4.5. Ethical Aspects
4.6. Analysis
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
CBT | Cognitive-behavioral therapy |
COVID | Coronavirus disease |
ECT | Electroconvulsive therapy |
HIC | High-income countries |
IPT | Interpersonal therapy |
LAMIC | Low and middle-income countries |
NNT | Numbers needed to treat |
PHQ | Patient health questionnaire |
rTMS | Repetitive transcranial magnetic stimulation |
SSRI | Selective serotonin reuptake inhibitors |
tDCS | Transcranial direct current stimulation |
TRD | Treatment-resistant depression |
VNS | Vagus nerve stimulation |
References
- World Health Organization Depressive Disorder (Depression). Available online: https://www.who.int/news-room/fact-sheets/detail/depression (accessed on 23 October 2024).
- GBD 2019 Mental Disorders Collaborators. Global, Regional, and National Burden of 12 Mental Disorders in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 2022, 9, 137. [Google Scholar] [CrossRef] [PubMed]
- Bromet, E.; Andrade, L.H.; Hwang, I.; Sampson, N.A.; Alonso, J.; de Girolamo, G.; de Graaf, R.; Demyttenaere, K.; Hu, C.; Iwata, N.; et al. Cross-National Epidemiology of DSM-IV Major Depressive Episode. BMC Med. 2011, 9, 90. [Google Scholar] [CrossRef] [PubMed]
- Ohayon, M.M.; Priest, R.G.; Guilleminault, C.; Caulet, M. The Prevalence of Depressive Disorders in the United Kingdom. Biol. Psychiatry 1999, 45, 300–307. [Google Scholar] [CrossRef] [PubMed]
- Arias de la Torre, J.; Vilagut, G.; Ronaldson, A.; Dregan, A.; Ricci-Cabello, I.; Hatch, S.L.; Serrano-Blanco, A.; Valderas, J.M.; Hotopf, M.; Alonso, J. Prevalence and Age Patterns of Depression in the United Kingdom. A Population-Based Study. J. Affect. Disord. 2021, 279, 164–172. [Google Scholar] [CrossRef]
- Dettmann, L.M.; Adams, S.; Taylor, G. Investigating the Prevalence of Anxiety and Depression during the First COVID-19 Lockdown in the United Kingdom: Systematic Review and Meta-Analyses. Br. J. Clin. Psychol. 2022, 61, 757–780. [Google Scholar] [CrossRef]
- Santomauro, D.F.; Mantilla Herrera, A.M.; Shadid, J.; Zheng, P.; Ashbaugh, C.; Pigott, D.M.; Abbafati, C.; Adolph, C.; Amlag, J.O.; Aravkin, A.Y.; et al. Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. Lancet 2021, 398, 1700–1712. [Google Scholar] [CrossRef]
- Akincigil, A.; Matthews, E.B. National Rates and Patterns of Depression Screening in Primary Care: Results from 2012 and 2013. Psychiatr. Serv. 2017, 68, 660–666. [Google Scholar] [CrossRef]
- Craven, M.A.; Bland, R. Depression in Primary Care: Current and Future Challenges. Can. J. Psychiatry Rev. Can. Psychiatr. 2013, 58, 442–448. [Google Scholar] [CrossRef]
- Yen Phi, H.N.; Quoc Tho, T.; Xuan Manh, B.; Anh Ngoc, T.; Minh Chau, P.T.; Trung Nghia, N.; Nghia, T.T.; Ngoc Quynh, H.H.; Huy, N.T.; Linh, N.T.; et al. Prevalence of Depressive Disorders in a Primary Care Setting in Ho Chi Minh City, Vietnam: A Cross-Sectional Epidemiological Study. Int. J. Psychiatry Med. 2023, 58, 86–101. [Google Scholar] [CrossRef]
- Abumadini, M.S. Depressive Disorders in Psychiatric Outpatient Clinic Attendees in Eastern Saudi Arabia. J. Fam. Community Med. 2003, 10, 43. [Google Scholar] [CrossRef]
- Mitchell, A.J.; McGlinchey, J.B.; Young, D.; Chelminski, I.; Zimmerman, M. Accuracy of Specific Symptoms in the Diagnosis of Major Depressive Disorder in Psychiatric Out-Patients: Data from the MIDAS Project. Psychol. Med. 2009, 39, 1107–1116. [Google Scholar] [CrossRef] [PubMed]
- Ali, M.; Jama, J.A. Depression among General Outpatient Department Attendees in Selected Hospitals in Somalia: Magnitude and Associated Factors. BMC Psychiatry 2024, 24, 579. [Google Scholar] [CrossRef] [PubMed]
- van Niekerk, M.; Walker, J.; Hobbs, H.; Magill, N.; Toynbee, M.; Steward, B.; Harriss, E.; Sharpe, M. The Prevalence of Psychiatric Disorders in General Hospital Inpatients: A Systematic Umbrella Review. J. Acad. Consult. Liaison Psychiatry 2022, 63, 567–578. [Google Scholar] [CrossRef] [PubMed]
- Walker, J.; Burke, K.; Wanat, M.; Fisher, R.; Fielding, J.; Mulick, A.; Puntis, S.; Sharpe, J.; Esposti, M.D.; Harriss, E.; et al. The Prevalence of Depression in General Hospital Inpatients: A Systematic Review and Meta-Analysis of Interview-Based Studies. Psychol. Med. 2018, 48, 2285–2298. [Google Scholar] [CrossRef]
- Wang, J.; Wu, X.; Lai, W.; Long, E.; Zhang, X.; Li, W.; Zhu, Y.; Chen, C.; Zhong, X.; Liu, Z.; et al. Prevalence of Depression and Depressive Symptoms among Outpatients: A Systematic Review and Meta-Analysis. BMJ Open 2017, 7, e017173. [Google Scholar] [CrossRef]
- Puthran, R.; Zhang, M.W.B.; Tam, W.W.; Ho, R.C. Prevalence of Depression amongst Medical Students: A Meta-Analysis. Med. Educ. 2016, 50, 456–468. [Google Scholar] [CrossRef]
- Li, W.; Zhao, Z.; Chen, D.; Peng, Y.; Lu, Z. Prevalence and Associated Factors of Depression and Anxiety Symptoms among College Students: A Systematic Review and Meta-Analysis. J. Child Psychol. Psychiatry 2022, 63, 1222–1230. [Google Scholar] [CrossRef]
- Rath, N.; Kar, S.; Kar, N. Mental Health in the University Campus: Emphasizing the Need for Preventive Health Actions. Indian J. Soc. Psychiatry 2021, 37, 225–229. [Google Scholar] [CrossRef]
- Kar, N.; Das, M.; Kar, B.; Rath, N.; Kar, S. Dimensional Distribution of Anxiety and Depression in College Students in a Rural Setting: Relationship with Stress, Well-Being, and Quality of Life. Indian J. Soc. Psychiatry 2024, 40, 411–417. [Google Scholar] [CrossRef]
- Amiri, S. Prevalence of Depression Disorder in Industrial Workers: A Meta-Analysis. Int. J. Occup. Saf. Ergon. JOSE 2022, 28, 1624–1635. [Google Scholar] [CrossRef]
- Bains, N.; Abdijadid, S. Major Depressive Disorder. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2024. [Google Scholar]
- Frank, P.; Batty, G.D.; Pentti, J.; Jokela, M.; Poole, L.; Ervasti, J.; Vahtera, J.; Lewis, G.; Steptoe, A.; Kivimäki, M. Association Between Depression and Physical Conditions Requiring Hospitalization. JAMA Psychiatry 2023, 80, 690–699. [Google Scholar] [CrossRef] [PubMed]
- DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Depression Is a Risk Factor for Noncompliance with Medical Treatment: Meta-Analysis of the Effects of Anxiety and Depression on Patient Adherence. Arch. Intern. Med. 2000, 160, 2101–2107. [Google Scholar] [CrossRef] [PubMed]
- Poletti, V.; Pagnini, F.; Banfi, P.; Volpato, E. The Role of Depression on Treatment Adherence in Patients with Heart Failure—A Systematic Review of the Literature. Curr. Cardiol. Rep. 2022, 24, 1995. [Google Scholar] [CrossRef]
- Katon, W.J. Epidemiology and Treatment of Depression in Patients with Chronic Medical Illness. Dialogues Clin. Neurosci. 2011, 13, 7. [Google Scholar] [CrossRef]
- Prina, A.M.; Cosco, T.D.; Dening, T.; Beekman, A.; Brayne, C.; Huisman, M. The Association between Depressive Symptoms in the Community, Non-Psychiatric Hospital Admission and Hospital Outcomes: A Systematic Review. J. Psychosom. Res. 2015, 78, 25–33. [Google Scholar] [CrossRef]
- Egede, L.E. Failure to Recognize Depression in Primary Care: Issues and Challenges. J. Gen. Intern. Med. 2007, 22, 701–703. [Google Scholar] [CrossRef]
- Fletcher, S.; Chondros, P.; Densley, K.; Murray, E.; Dowrick, C.; Coe, A.; Hegarty, K.; Davidson, S.; Wachtler, C.; Mihalopoulos, C.; et al. Matching Depression Management to Severity Prognosis in Primary Care: Results of the Target-D Randomised Controlled Trial. Br. J. Gen. Pract. 2021, 71, e85–e94. [Google Scholar] [CrossRef]
- Fekadu, A.; Demissie, M.; Birhane, R.; Medhin, G.; Bitew, T.; Hailemariam, M.; Minaye, A.; Habtamu, K.; Milkias, B.; Petersen, I.; et al. Under Detection of Depression in Primary Care Settings in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis. Syst. Rev. 2022, 11, 21. [Google Scholar] [CrossRef]
- American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th ed.; American Psychiatric Association: Washington, DC, USA, 2013. [Google Scholar]
- World Health Organization ICD-11 for Mortality and Morbidity Statistics. Available online: https://icd.who.int/browse/2024-01/mms/en#334423054 (accessed on 29 March 2024).
- Simon, G.E.; Moise, N.; Mohr, D.C. Management of Depression in Adults: A Review. JAMA 2024, 332, 141–152. [Google Scholar] [CrossRef]
- Riera-Serra, P.; Navarra-Ventura, G.; Castro, A.; Gili, M.; Salazar-Cedillo, A.; Ricci-Cabello, I.; Roldán-Espínola, L.; Coronado-Simsic, V.; García-Toro, M.; Gómez-Juanes, R.; et al. Clinical Predictors of Suicidal Ideation, Suicide Attempts and Suicide Death in Depressive Disorder: A Systematic Review and Meta-Analysis. Eur. Arch. Psychiatry Clin. Neurosci. 2024, 274, 1543–1563. [Google Scholar] [CrossRef]
- Arroll, B.; Elley, C.R.; Fishman, T.; Goodyear-Smith, F.A.; Kenealy, T.; Blashki, G.; Kerse, N.; Macgillivray, S. Antidepressants versus Placebo for Depression in Primary Care. Cochrane Database Syst. Rev. 2009, 2009, CD007954. [Google Scholar] [CrossRef] [PubMed]
- Cipriani, A.; Furukawa, T.A.; Geddes, J.R.; Malvini, L.; Signoretti, A.; McGuire, H.; Churchill, R.; Nakagawa, A.; Barbui, C.; MANGA Study Group. Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults with Acute Major Depression? A Systematic Review and Meta-Analysis. J. Clin. Psychiatry 2008, 69, 1732–1742. [Google Scholar] [CrossRef]
- Cuijpers, P.; Sijbrandij, M.; Koole, S.L.; Andersson, G.; Beekman, A.T.; Reynolds, C.F. Adding Psychotherapy to Antidepressant Medication in Depression and Anxiety Disorders: A Meta-Analysis. World Psychiatry Off. J. World Psychiatr. Assoc. WPA 2014, 13, 56–67. [Google Scholar] [CrossRef]
- Hasin, D.S.; Sarvet, A.L.; Meyers, J.L.; Saha, T.D.; Ruan, W.J.; Stohl, M.; Grant, B.F. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry 2018, 75, 336–346. [Google Scholar] [CrossRef]
- Saver, B.G.; Van-Nguyen, V.; Keppel, G.; Doescher, M.P. A Qualitative Study of Depression in Primary Care: Missed Opportunities for Diagnosis and Education. J. Am. Board Fam. Med. JABFM 2007, 20, 28–35. [Google Scholar] [CrossRef] [PubMed]
- Kato, E.; Borsky, A.E.; Zuvekas, S.H.; Soni, A.; Ngo-Metzger, Q. Missed Opportunities for Depression Screening and Treatment in the United States. J. Am. Board Fam. Med. JABFM 2018, 31, 389–397. [Google Scholar] [CrossRef] [PubMed]
- Rhodes, K.V. Mood Disorders in the Emergency Department: The Challenge of Linking Patients to Appropriate Services. Gen. Hosp. Psychiatry 2008, 30, 1–3. [Google Scholar] [CrossRef]
- Mekonen, T.; Chan, G.C.K.; Connor, J.P.; Hides, L.; Leung, J. Estimating the Global Treatment Rates for Depression: A Systematic Review and Meta-Analysis. J. Affect. Disord. 2021, 295, 1234–1242. [Google Scholar] [CrossRef]
- Evans-Lacko, S.; Aguilar-Gaxiola, S.; Al-Hamzawi, A.; Alonso, J.; Benjet, C.; Bruffaerts, R.; Chiu, W.T.; Florescu, S.; de Girolamo, G.; Gureje, O.; et al. Socio-Economic Variations in the Mental Health Treatment Gap for People with Anxiety, Mood, and Substance Use Disorders: Results from the WHO World Mental Health (WMH) Surveys. Psychol. Med. 2018, 48, 1560–1571. [Google Scholar] [CrossRef]
- Yan, G.; Zhang, Y.; Wang, S.; Yan, Y.; Liu, M.; Tian, M.; Tian, W. Global, Regional, and National Temporal Trend in Burden of Major Depressive Disorder from 1990 to 2019: An Analysis of the Global Burden of Disease Study. Psychiatry Res. 2024, 337, 115958. [Google Scholar] [CrossRef]
- Harris, M.G.; Kazdin, A.E.; Chiu, W.T.; Sampson, N.A.; Aguilar-Gaxiola, S.; Al-Hamzawi, A.; Alonso, J.; Altwaijri, Y.; Andrade, L.H.; Cardoso, G.; et al. Findings from World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients with Major Depressive Disorder. JAMA Psychiatry 2020, 77, 830–841. [Google Scholar] [CrossRef] [PubMed]
- Chaimowitz, G.A.; Links, P.S.; Padgett, R.W.; Carr, A.C. Treatment-Resistant Depression: A Survey of Practice Habits of Canadian Psychiatrists. Can. J. Psychiatry Rev. Can. Psychiatr. 1991, 36, 353–356. [Google Scholar] [CrossRef] [PubMed]
- Branjerdporn, G.; Sarma, S.; McCosker, L.; Dong, V.; Martin, D.; Loo, C. “ECT Should Never Stop”: Exploring the Experiences and Recommendations of ECT Clinical Directors and Anesthetists about ECT during the COVID-19 Pandemic. Front. Psychiatry 2022, 13, 946748. [Google Scholar] [CrossRef] [PubMed]
- NICE Depression in Adults: Recognition and Management|Guidance|. Available online: https://www.nice.org.uk/guidance/cg90/chapter/Recommendations#step-1-recognition-assessment-and-initial-management (accessed on 13 December 2020).
- NICE Recommendations|Depression in Adults: Treatment and Management|Guidance|NICE. Available online: https://www.nice.org.uk/guidance/ng222/chapter/Recommendations#treatment-for-a-new-episode-of-more-severe-depression (accessed on 22 August 2024).
- Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a Brief Depression Severity Measure. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef]
- Arroll, B.; Goodyear-Smith, F.; Crengle, S.; Gunn, J.; Kerse, N.; Fishman, T.; Falloon, K.; Hatcher, S. Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population. Ann. Fam. Med. 2010, 8, 348. [Google Scholar] [CrossRef]
- WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research; World Health Organization: Geneva, Switzerland, 1993. [Google Scholar]
- World Health Organization. The ICD-10 Classification of Mental Behavioural Disorders—Clinical Descriptions and Diagnostic Guidelines, 10th ed.; World Health Organization: Geneva, Switzerland, 1992. [Google Scholar]
- Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; Erbaugh, J. An Inventory for Measuring Depression. Arch. Gen. Psychiatry 1961, 4, 561–571. [Google Scholar] [CrossRef]
- Zung, W.K. A Self-Rating Depression Scale. Arch. Gen. Psychiatry 1965, 12, 63–70. [Google Scholar] [CrossRef]
- Hamilton, M. A Rating Scale for Depression. J. Neurol. Neurosurg. Psychiatry 1960, 23, 56. [Google Scholar] [CrossRef]
- Montgomery, S.A.; Asberg, M. A New Depression Scale Designed to Be Sensitive to Change. Br. J. Psychiatry J. Ment. Sci. 1979, 134, 382–389. [Google Scholar] [CrossRef]
- NICE (National Institute for Health and Care Excellence). Overview|Depression in Adults with a Chronic Physical Health Problem: Recognition and Management|Guidance|NICE. Available online: https://www.nice.org.uk/guidance/cg91 (accessed on 25 December 2024).
- Kruizinga, J.; Liemburg, E.; Burger, H.; Cipriani, A.; Geddes, J.; Robertson, L.; Vogelaar, B.; Nolen, W.A. Pharmacological Treatment for Psychotic Depression. Cochrane Database Syst. Rev. 2021, 12, CD004044. [Google Scholar] [CrossRef]
- Lassen, R.H.; Gonçalves, W.; Gherman, B.; Coutinho, E.; Nardi, A.E.; Peres, M.A.; Appolinario, J.C. Medication Non-Adherence in Depression: A Systematic Review and Metanalysis. Trends Psychiatry Psychother. 2024. ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Unni, E.J.; Gupta, S.; Sternbach, N. Reasons for Non-Adherence with Antidepressants Using the Medication Adherence Reasons Scale in Five European Countries and United States. J. Affect. Disord. 2024, 344, 446–450. [Google Scholar] [CrossRef] [PubMed]
- Taylor, M.J.; Rudkin, L.; Bullemor-Day, P.; Lubin, J.; Chukwujekwu, C.; Hawton, K. Strategies for Managing Sexual Dysfunction Induced by Antidepressant Medication. Cochrane Database Syst. Rev. 2013, 5, CD003382. [Google Scholar] [CrossRef] [PubMed]
- Montejo, A.L.; Prieto, N.; de Alarcón, R.; Casado-Espada, N.; de la Iglesia, J.; Montejo, L. Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach. J. Clin. Med. 2019, 8, 1640. [Google Scholar] [CrossRef] [PubMed]
- McIntyre, R.S.; Alsuwaidan, M.; Baune, B.T.; Berk, M.; Demyttenaere, K.; Goldberg, J.F.; Gorwood, P.; Ho, R.; Kasper, S.; Kennedy, S.H.; et al. Treatment-resistant Depression: Definition, Prevalence, Detection, Management, and Investigational Interventions. World Psychiatry 2023, 22, 394–412. [Google Scholar] [CrossRef]
- Rush, A.J.; Trivedi, M.H.; Wisniewski, S.R.; Nierenberg, A.A.; Stewart, J.W.; Warden, D.; Niederehe, G.; Thase, M.E.; Lavori, P.W.; Lebowitz, B.D.; et al. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. Am. J. Psychiatry 2006, 163, 1905–1917. [Google Scholar] [CrossRef]
- Vida, R.G.; Sághy, E.; Bella, R.; Kovács, S.; Erdősi, D.; Józwiak-Hagymásy, J.; Zemplényi, A.; Tényi, T.; Osváth, P.; Voros, V. Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Adjunctive Therapy for Major Depressive Disorder (MDD) after Two Antidepressant Treatment Failures: Meta-Analysis of Randomized Sham-Controlled Trials. BMC Psychiatry 2023, 23, 545. [Google Scholar] [CrossRef]
- Maughan, D.; Molodynski, A. An International Perspective on the Acceptability and Sustainability of Electroconvulsive Therapy. BJPsych Int. 2016, 13, 10–12. [Google Scholar] [CrossRef]
- Belay, Y.B.; Engel, L.; Lee, Y.Y.; Le, N.; Mihalopoulos, C. Cost Effectiveness of Pharmacological and Non-Pharmacological Treatments for Depression in Low- and Middle-Income Countries: A Systematic Literature Review. PharmacoEconomics 2023, 41, 651–673. [Google Scholar] [CrossRef]
- Rathod, S.; Pinninti, N.; Irfan, M.; Gorczynski, P.; Rathod, P.; Gega, L.; Naeem, F. Mental Health Service Provision in Low- and Middle-Income Countries. Health Serv. Insights 2017, 10, 1178632917694350. [Google Scholar] [CrossRef]
- NICE (National Institute for Health and Care Excellence). Recommendations|Bipolar Disorder: Assessment and Management|Guidance|NICE. Available online: https://www.nice.org.uk/guidance/cg185/chapter/Recommendations (accessed on 24 December 2024).
- Goes, F.S. Diagnosis and Management of Bipolar Disorders. BMJ 2023, 381, e073591. [Google Scholar] [CrossRef] [PubMed]
- Chiang, K.S.; Miklowitz, D.J. Psychotherapy in Bipolar Depression: Effective Yet Underused. Psychiatr. Ann. 2023, 53, 58. [Google Scholar] [CrossRef] [PubMed]
- McMahon, K.; Herr, N.R.; Zerubavel, N.; Hoertel, N.; Neacsiu, A.D. Psychotherapeutic Treatment of Bipolar Depression. Psychiatr. Clin. N. Am. 2016, 39, 35–56. [Google Scholar] [CrossRef] [PubMed]
- Yilmaz, S.; Huguet, A.; Kisely, S.; Rao, S.; Wang, J.; Baur, K.; Price, M.; O’Mahen, H.; Wright, K. Do Psychological Interventions Reduce Symptoms of Depression for Patients with Bipolar I or II Disorder? A Meta-Analysis. J. Affect. Disord. 2022, 301, 193–204. [Google Scholar] [CrossRef]
- Mamukashvili-Delau, M.; Koburger, N.; Dietrich, S.; Rummel-Kluge, C. Long-Term Efficacy of Internet-Based Cognitive Behavioral Therapy Self-Help Programs for Adults with Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials. JMIR Ment. Health 2023, 10, e46925. [Google Scholar] [CrossRef]
- Stuart, R.; Fischer, H.; Leitzke, A.S.; Becker, D.; Saheba, N.; Coleman, K.J. The Effectiveness of Internet-Based Cognitive Behavioral Therapy for the Treatment of Depression in a Large Real-World Primary Care Practice: A Randomized Trial. Perm. J. 2022, 26, 53–60. [Google Scholar] [CrossRef]
- Thase, M.E.; Wright, J.H.; Eells, T.D.; Barrett, M.S.; Wisniewski, S.R.; Balasubramani, G.K.; McCrone, P.; Brown, G.K. Improving Efficiency of Psychotherapy for Depression: Computer-Assisted Cognitive-Behavior Therapy Versus Standard Cognitive-Behavior Therapy. Am. J. Psychiatry 2018, 175, 242–250. [Google Scholar] [CrossRef]
- Kim, W.; Lim, S.-K.; Chung, E.-J.; Woo, J.-M. The Effect of Cognitive Behavior Therapy-Based Psychotherapy Applied in a Forest Environment on Physiological Changes and Remission of Major Depressive Disorder. Psychiatry Investig. 2009, 6, 245–254. [Google Scholar] [CrossRef]
- Lusk, P.; Melnyk, B.M. The Brief Cognitive-Behavioral COPE Intervention for Depressed Adolescents: Outcomes and Feasibility of Delivery in 30-Minute Outpatient Visits. J. Am. Psychiatr. Nurses Assoc. 2011, 17, 226–236. [Google Scholar] [CrossRef]
- Tursi, M.F.d.S.; Baes, C.v.W.; Camacho, F.R.d.B.; Tofoli, S.M.d.C.; Juruena, M.F. Effectiveness of Psychoeducation for Depression: A Systematic Review. Aust. N. Z. J. Psychiatry 2013, 47, 1019–1031. [Google Scholar] [CrossRef]
- Katsuki, F.; Watanabe, N.; Yamada, A.; Hasegawa, T. Effectiveness of Family Psychoeducation for Major Depressive Disorder: Systematic Review and Meta-Analysis. BJPsych Open 2022, 8, e148. [Google Scholar] [CrossRef] [PubMed]
- Conejo-Cerón, S.; Bellón, J.Á.; Motrico, E.; Campos-Paíno, H.; Martín-Gómez, C.; Ebert, D.D.; Buntrock, C.; Gili, M.; Moreno-Peral, P. Moderators of Psychological and Psychoeducational Interventions for the Prevention of Depression: A Systematic Review. Clin. Psychol. Rev. 2020, 79, 101859. [Google Scholar] [CrossRef] [PubMed]
- Marx, W.; Manger, S.H.; Blencowe, M.; Murray, G.; Ho, F.Y.-Y.; Lawn, S.; Blumenthal, J.A.; Schuch, F.; Stubbs, B.; Ruusunen, A.; et al. Clinical Guidelines for the Use of Lifestyle-Based Mental Health Care in Major Depressive Disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) Taskforce. World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry 2023, 24, 333–386. [Google Scholar] [CrossRef]
- Sarris, J.; O’Neil, A.; Coulson, C.E.; Schweitzer, I.; Berk, M. Lifestyle Medicine for Depression. BMC Psychiatry 2014, 14, 107. [Google Scholar] [CrossRef]
- Kvam, S.; Kleppe, C.L.; Nordhus, I.H.; Hovland, A. Exercise as a Treatment for Depression: A Meta-Analysis. J. Affect. Disord. 2016, 202, 67–86. [Google Scholar] [CrossRef]
- Greenberg, P.E.; Fournier, A.-A.; Sisitsky, T.; Simes, M.; Berman, R.; Koenigsberg, S.H.; Kessler, R.C. The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). PharmacoEconomics 2021, 39, 653–665. [Google Scholar] [CrossRef]
- König, H.; König, H.-H.; Konnopka, A. The Excess Costs of Depression: A Systematic Review and Meta-Analysis. Epidemiol. Psychiatr. Sci. 2019, 29, e30. [Google Scholar] [CrossRef]
- Barney, L.J.; Griffiths, K.M.; Jorm, A.F.; Christensen, H. Stigma about Depression and Its Impact on Help-Seeking Intentions. Aust. N. Z. J. Psychiatry 2006, 40, 51–54. [Google Scholar] [CrossRef]
Themes and Subthemes |
---|
|
|
|
|
|
|
|
|
|
|
|
|
Management Strategies | HIC n (%) | LAMIC n (%) | Total n (%) |
---|---|---|---|
Antidepressants with second-generation antipsychotics | 51 (72.9) | 54 (80.6) | 105 (76.6) |
Switching antidepressants | 56 (80.0) | 47 (70.1) | 103 (75.2) |
Two antidepressants | 45 (64.3) | 45 (67.2) | 90 (65.7) |
Antidepressant and lithium | 39 (55.7) | 49 (73.1) | 88 (64.2) |
Psychotherapy | 46 (65.7) | 42 (62.7) | 88 (64.2) |
Electroconvulsive therapy | 33 (47.1) | 48 (71.6) | 81 (59.1) |
Increased trial length of antidepressant | 29 (41.4) | 25 (37.3) | 54 (39.4) |
Antidepressant and valproate/carbamazepine/lamotrigine | 27 (38.6) | 24 (35.8) | 51 (37.2) |
Intravenous ketamine or intranasal esketamine | 8 (11.4) | 18 (26.9) | 26 (19.0) |
Antidepressant with thyroid hormone | 5 (7.1) | 21 (31.3) | 26 (19.0) |
Bupropion | 8 (11.4) | 17 (25.4) | 25 (18.2) |
Transcranial magnetic stimulation | 8 (11.4) | 8 (11.9) | 16 (11.7) |
Strategies | HIC n (%) | LAMIC n (%) | Total n (%) |
---|---|---|---|
Lithium and antidepressant | 48 (68.6) | 45 (67.2) | 93 (67.9) |
Atypical antipsychotic and antidepressant | 46 (65.7) | 45 (67.2) | 91 (66.4) |
Lamotrigine and antidepressant | 33 (47.1) | 37 (55.2) | 70 (51.1) |
Valproate and antidepressant | 22 (31.4) | 31 (46.3) | 53 (38.7) |
Psychotherapy | 19 (27.1) | 21 (31.3) | 40 (29.2) |
Two mood stabilizers | 10 (14.3) | 17 (25.4) | 27 (19.7) |
No antidepressant | 12 (17.1) | 10 (14.9) | 22 (16.1) |
Others | 4 (5.7) | 11 (16.4) | 15 (10.9) |
Side effects | HIC n (%) | LAMIC n (%) | Total n (%) |
---|---|---|---|
Sexual problems | 31 (44.4) | 32 (47.8) | 63 (46.0) |
Weight gain | 26 (37.1) | 23 (34.3) | 48 (35.0) |
Sedation | 15 (21.4) | 30 (44.8) | 43 (31.4) |
Gastrointestinal side effects | 19 (27.1) | 22 (32.9) | 41 (29.9) |
Agitation | 9 (12.8) | 9 (13.4) | 17 (12.4) |
Insomnia | 4 (5.7) | 6 (9.0) | 10 (7.3) |
Fatigue | 3 (4.3) | 2 (3.0) | 5 (3.6) |
Other | 14 (20.0) | 12 (17.9) | 26 (19.0) |
Challenges | HIC n (%) | LAMIC n (%) | Total n (%) |
---|---|---|---|
Non-adherence | 54 (77.1) | 59 (88.1) | 113 (82.5) |
Unresolved psychological stress | 41 (58.6) | 50 (74.6) | 91 (66.4) |
Missed appointments | 42 (60.0) | 45 (67.2) | 87 (63.5) |
Personality disorders | 49 (70.0) | 37 (55.2) | 86 (62.8) |
Substance use | 47 (67.1) | 36 (53.7) | 83 (60.6) |
Physical comorbidities | 40 (57.1) | 29 (43.3) | 69 (50.4) |
Other psychiatric comorbidities | 35 (50.0) | 26 (38.8) | 61 (44.5) |
Other | 3 (4.3) | 4 (6.0) | 7 (5.1) |
Themes and Subthemes |
---|
|
|
|
|
|
|
|
|
|
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kar, N. Challenges in Managing Depression in Clinical Practice: Result of a Global Survey. Pharmacoepidemiology 2025, 4, 5. https://doi.org/10.3390/pharma4010005
Kar N. Challenges in Managing Depression in Clinical Practice: Result of a Global Survey. Pharmacoepidemiology. 2025; 4(1):5. https://doi.org/10.3390/pharma4010005
Chicago/Turabian StyleKar, Nilamadhab. 2025. "Challenges in Managing Depression in Clinical Practice: Result of a Global Survey" Pharmacoepidemiology 4, no. 1: 5. https://doi.org/10.3390/pharma4010005
APA StyleKar, N. (2025). Challenges in Managing Depression in Clinical Practice: Result of a Global Survey. Pharmacoepidemiology, 4(1), 5. https://doi.org/10.3390/pharma4010005